Recommendation 1 | R1 | Studies on weaning from a prolonged infusion of dexmedetomidine |
---|---|---|
Recommendation 2 | R2 | Studies on the efficacy of drug rotation (analgesics or sedatives) protocols |
Recommendation 4 | R4.1 | Studies on the prolonged infusion of ketamine |
R4.2 | Studies on efficacy and safety of other drugs used in difficult analgesia and sedation (i.e., sevoflurane) | |
Recommendation 5 | R5 | Studies on length of treatment with neuromuscular blocking agents |
Recommendation 6 | R6 | Studies on continuous processed EEG in infants |
Recommendation 7 | R7.1 | Studies on preventing and treatment of sleep disorders in paediatric intensive care unit |
R7.2 | Studies on monitoring the quality of sleep in paediatric intensive care unit with tools other than polysomnography | |
Recommendation 8 | R8.1 | Studies on the efficacy of alpha agonists in reducing the incidence of delirium in critically ill patients |
R8.2 | Studies on the impact of reduction of modifiable factors in paediatric delirium | |
Recommendation 9 | R9 | Studies on pharmacologic prevention and treatment of paediatric delirium |
Recommendation 11 | R11 | Studies on weaning after ketamine and alpha agonists infusions |
Recommendation 12 | R12 | Studies on preventing withdrawal syndrome from adopting strategies of weaning or pharmacologic strategies |
Recommendation 15 | R15 | Studies describing characteristics of paediatric palliative sedation in children in intensive care unit |
Recommendation 16 | R16.1 | Studies on pharmacological interactions between patient’s chronic therapy and analgesic and sedative treatment administered in intensive care unit |
R16.2 | Studies on the development of tools dedicated to children with developmental delay admitted to paediatric intensive care unit |